Showing results (411-420 of 466) with videos related to

Sort By:
Pageof 47
Rheumatology (Oxford, England)|June 22, 2022
Late skin fibrosis in systemic sclerosis: a study from the EUSTAR cohortMichael Hughes, Suiyuan Huang, Juan Jose Alegre-Sancho, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2016
OX40L blockade protects against inflammation-driven fibrosisMuriel Elhai, Jérôme Avouac, Anna Maria Hoffmann-Vold, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 17, 2021
Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021Lin T Brandal, Emily MacDonald, Lamprini Veneti, et al.
Chest|March 27, 2026
Clinical profiles and lung function trajectories of IIM-ILD patients: A comparative study of pulmonology and rheumatology settingsRachele Vallara, Helena Andersson, Ilaria Bassi, et al.
European Journal of Internal Medicine|May 26, 2026
Anti-Ro/SSA and rheumatoid factor antibodies are associated with more severe lung involvement in patients with systemic sclerosis: a study from the EUSTAR databaseBlaž Burja, Marouane Boubaya, Cosimo Bruni, et al.
Rheumatology (Oxford, England)|July 11, 2025
'Am I doing this right?' Physician perceptions of the global assessment in clinical trials of systemic sclerosisHana Sabanovic, John D Pauling, Murray Baron, et al.
The New England Journal of Medicine|May 19, 2025
Nerandomilast in Patients with Progressive Pulmonary FibrosisToby M Maher, Shervin Assassi, Arata Azuma, et al.
Rheumatology (Oxford, England)|October 4, 2018
Mortality and causes of death across the systemic connective tissue diseases and the primary systemic vasculitidesTorhild Garen, Karoline Lerang, Anna-Maria Hoffmann-Vold, et al.
Thorax|October 5, 2023
Phenotyping by persistent inflammation in systemic sclerosis associated interstitial lung disease: a EUSTAR database analysisSabina Guler, Adela-Cristina Sarbu, Odile Stalder, et al.
Arthritis Research & Therapy|November 1, 2024
Does regression of skin thickening predict improvement of internal organ involvement and survival in patients with diffuse cutaneous systemic sclerosis? A EUSTAR analysisAnja Wyss, Suzana Jordan, Nicole Graf, et al.
Pageof 47